Medically reviewed by Dr Sin Yong · Last reviewed · 8 min read · Jump to questions
Published 16 August 2026 · Reviewed by Dr Sin Yong · All articles by Dr Sin Yong
Most people arrive having decided they have sensitive skin. They have tried gentler cleansers, then gentler ones again, and the redness is still there. That is usually the first clue that it is something else.
Rosacea treatment in Singapore combines medical management, topical and sometimes oral, with conservative laser directed at inflammation and visible vessels, supported by daily sun protection and barrier care. Rosacea is managed rather than cured, so the aim is a calmer baseline and fewer, shorter flares. Subtype, triggers and skin type are assessed first, in person.
Sensitive skin describes reactivity — to a product, to weather, to friction. It is a description of behaviour.
Rosacea is a chronic inflammatory condition of the central facial skin, involving both the blood vessels and the immune response. It has a characteristic distribution: cheeks, nose, chin, central forehead. It has a course, with flares and quieter periods. And it does not resolve by removing an irritant, because the driver is not external.
“Rosacea is not sensitive skin that got worse. It is a different condition, and treating it as sensitivity is why people spend years switching cleansers while the inflammation continues underneath.”
Dr Sin YongOn the commonest misdiagnosis
Rosacea treatment in Singapore is planned by subtype, because flushing, red bumps, thickened skin and sore eyes respond to different things. Common signs are central facial redness, flushing, burning or stinging, bumps without blackheads, visible thread veins and gritty eyes. Most people have more than one subtype, so the plan usually combines medical treatment, gentle skincare, sun protection and, where it fits, conservative laser.
| Subtype | What you notice | Usually tried first | Not the first move |
|---|---|---|---|
| Erythematotelangiectatic | Flushing, fixed central redness, visible vessels | Trigger control, sun protection and barrier care; inflammation-directed laser for diffuse redness; vessel-directed laser for established thread veins | Scrubs, strong acids and high-heat settings |
| Papulopustular | Red bumps and pustules with no blackheads | Topical anti-inflammatory treatment; an oral course where the inflammation is widespread | Drying acne regimens that strip the barrier |
| Phymatous | Thickening and enlarged pores, most often at the nose | Medical treatment early on; referral for specialist recontouring, which can involve ablative laser or surgery, once thickening is established | Expecting creams to reverse thickened tissue |
| Ocular | Dry, gritty or irritated eyes and inflamed lid margins | Referral to an eye specialist, alongside care of the facial skin | Treating the skin and ignoring the eyes |
Dr Sin Yong assesses subtype, triggers and skin type in person, and separates the inflammatory part of rosacea from the vascular part, because they are treated differently. Where redness is diffuse and inflammatory, R2 Glow, long-pulsed 755 nm and 1064 nm, is generally reached for first. Established individual vessels are a separate target, set out on the facial thread veins page. Where redness comes with textural change, 675 nm is considered. Settings stay conservative, because heat is itself a rosacea trigger. Medicines and laser are often used together, and Demodex overgrowth is distinguished at examination. The vascular laser comparison explains how devices differ.
Erythematotelangiectatic — persistent central redness with visible vessels. Flushing is often the earliest symptom, long before anything is fixed.
Papulopustular — inflammatory papules and pustules on a background of redness. This is the subtype most often mistaken for acne, and the distinguishing feature is what is absent: no comedones. No blackheads, no whiteheads. If someone has been treating you for adult acne and nothing has shifted, this is worth raising.
Phymatous — thickening of the skin with enlargement of the sebaceous glands, most commonly at the nose. It develops gradually and is more common in men.
Ocular — dryness, grittiness, irritation and lid margin inflammation. Reported in a substantial proportion of patients and frequently unrecognised, because people do not connect sore eyes with facial redness.
More than one subtype is often present at once. The plan follows what is actually there, not the label.
The trigger list is consistent across populations: heat, sun exposure, alcohol, spicy food, emotional stress, hot drinks.
Look at the first two. Singapore sits one degree off the equator. Ambient heat is constant, and UV is high year-round — through cloud, through car windows, walking to lunch. Neither is avoidable the way a glass of red wine is.
Which changes the emphasis. Where trigger avoidance carries a plan in a temperate climate, here more of the work goes into reducing the inflammatory baseline so that unavoidable triggers produce a smaller response. Daily sunscreen is not an afterthought in this condition — it is part of the treatment.
Barrier dysfunction is part of rosacea rather than incidental to it. So the instinct that helps with acne actively harms here.
Aggressive exfoliation, high-strength actives, stripping cleansers, scrubs, and layered treatment products all disrupt a barrier that is already compromised. People often escalate precisely because nothing is working — and the escalation is what keeps it going.
The same applies to energy-based treatment. Heat is a trigger. Aggressive settings in a condition defined partly by vascular reactivity can provoke rather than settle it, which is why conservative parameters matter more here than device choice.
Rosacea has an inflammatory component and a vascular one, and they are addressed differently.
Approaches directed at inflammatory activity act on the process rather than only on its visible result — upstream rather than downstream. R2 Glow uses long-pulsed 755 nm and 1064 nm directed at inflammatory activity within the skin, and it is what is generally reached for first where redness is diffuse and the picture is inflammatory.
Where telangiectasia is established — individual visible vessels rather than general flush — the vessels themselves are a separate target, and that is assessed on its own terms.
Where the picture includes textural change and background redness together, 675 nm reaches the reticular dermis at 2–3 mm and is absorbed by collagen rather than by water, which makes it relevant to the vascular and structural elements at once.
Topical and oral medical management remains central, and some agents require assessment and monitoring before any course begins.
Response varies with subtype, duration, skin type and previous treatment. Rosacea is chronic and relapsing; management aims at reducing activity and lengthening intervals between flares rather than at cure. Suitability is assessed in person.
Rosacea laser in Singapore is chosen by the kind of redness, not by the name on the machine. Flushing, fixed background redness, visible vessels and bumps are four different targets, and a laser that suits one can be the wrong tool for another. Vessel-directed wavelengths are absorbed by haemoglobin and close vessels by heat; inflammation-directed protocols act on the activity behind diffuse redness; and no laser treats the papules and pustules, which remain a medical question. The table sets out where each common option sits, including two that are not offered here.
| Laser | Flushing | Fixed redness | Visible vessels | Bumps | Where it is explained |
|---|---|---|---|---|---|
| Pulsed-dye laser, 585 to 595 nm (Vbeam is one brand) | No laser switches flushing off; it is a neurovascular event | Vessel-directed; absorbed by haemoglobin across a field of redness, with bruising at some settings | Suits fine, superficial vessels | Not a treatment for papules or pustules | Not offered here; see the vascular laser comparison |
| Yellow laser, 577 nm | Same limit; flushing is managed medically and by triggers | Vessel-directed at a neighbouring wavelength to pulsed-dye | Suits fine, superficial vessels | Not a treatment for papules or pustules | Not offered here; see yellow vs pico vs pulsed-dye |
| Long-pulsed Nd:YAG, 1064 nm | Same limit | Reaches deeper and spares epidermal melanin, which matters in Fitzpatrick III to V skin | Suits larger or blue-purple vessels; used as a vessel-directed laser for telangiectasia | Not a treatment for papules or pustules | Facial thread veins |
| R2 Glow (long-pulsed 755 nm and 1064 nm) | Same limit; sits inside a medical plan | Directed at inflammatory activity behind diffuse redness, at conservative settings | Established single vessels are a separate target, not what R2 Glow is for | Does not replace topical or oral medical treatment | R2 Glow |
| 675 nm (少女光 Laser, DEKA RedTouch Pro) | Same limit | Absorbed by collagen at the reticular dermis, so it is considered where background redness and textural change occur together | Not a vessel-directed wavelength | Does not settle active papules on its own | 675 nm laser |
Pico lasers at 532, 785 and 1064 nm deliver picosecond pulses built to shatter pigment particles by a pressure effect. A vessel is not a particle. Closing it needs heat held in the vessel wall for milliseconds, which a picosecond pulse does not deliver. Treating rosacea redness as if it were pigment adds heat to skin that is already inflamed, and heat is itself a rosacea trigger. The what pico laser cannot do page covers this in more detail.
In practice, Dr Sin Yong separates the inflammatory part of rosacea from the vascular part at examination. Diffuse inflammatory redness is generally approached with R2 Glow; established thread veins are a separate, vessel-directed target; redness with textural change brings 675 nm into consideration. Settings stay conservative in every case, and laser sits alongside medical treatment, trigger review and barrier-respecting skincare rather than replacing them. Whether any laser is appropriate is decided in person, and an active flare is a reason to wait.
Rosacea is managed, not cured. Anyone promising that it will clear for good is describing something other than rosacea.
What is realistic is a lower inflammatory baseline, fewer and shorter flares, and a face that is less reactive to the things that cannot be avoided in this climate. For most patients that is the difference that matters day to day.
Rosacea medicines are chosen by which features are present: topical agents for papules, pustules and inflammation, oral treatment for more widespread inflammatory disease, and separate measures for persistent redness and the eyes. Beyond basic skincare, each needs a doctor's assessment, and the prescription-only agents need a prescription.
Commonly used topical agents include azelaic acid, metronidazole and ivermectin, each acting on the inflammatory, papulopustular side of the condition. For persistent background redness there are topical agents that temporarily narrow superficial vessels; the effect lasts only while they are used. Where inflammation is more extensive, a tetracycline-class antibiotic such as doxycycline may be prescribed, often at a lower, anti-inflammatory dose and for a defined period. In stubborn cases a low-dose oral retinoid is sometimes considered, which requires monitoring and strict pregnancy prevention.
Steroid creams are a particular trap: they blanch redness briefly and then let it rebound. Gritty or irritated eyes may be referred to an eye specialist. Side effects, pregnancy plans and other medicines are reviewed before any course begins, and medicines and laser are often used together rather than as alternatives, because they act on different parts of the condition.
| Option | What it does | What it cannot do | Typical recovery | Who it tends to suit |
|---|---|---|---|---|
| Topical medical treatment (for example azelaic acid, metronidazole or ivermectin); prescription where required | Acts on the inflammatory component, settling papules and pustules | Close established visible vessels or reverse thickened skin | Not a procedure; some agents sting at first | Papulopustular rosacea, and maintenance between flares |
| Oral medical treatment (for example doxycycline); prescription-only | Reduces more widespread inflammatory papules and pustules, and is used in some ocular rosacea | Treat fixed redness or visible vessels; it is a time-limited course, not a cure | Not a procedure; side effects and sun sensitivity are discussed beforehand | Moderate to severe inflammatory rosacea, or where topical treatment alone has not settled it |
| R2 Glow (long-pulsed 755 nm and 1064 nm) | Directed at inflammatory activity within the skin, at conservative settings | Replace medical management or act on phymatous thickening | Usually transient redness | Diffuse redness where the picture is mainly inflammatory |
| 少女光 Laser (675 nm) | Absorbed by collagen at the reticular dermis, so it is relevant to the vascular and structural elements together | Settle active papules on its own or switch off the underlying condition | Varies with settings; discussed before treatment | Background redness combined with textural change |
| Vessel-directed laser for telangiectasia | Light absorbed by haemoglobin heats and seals individual visible vessels | Stop new vessels forming if sun exposure and rosacea activity continue | Varies with wavelength and settings; discussed before treatment | Established individual thread veins rather than general flushing |
| Referral to an eye specialist, or to a dermatology or plastic surgery specialist | Ocular rosacea is assessed by an eye specialist; established phymatous thickening may be referred for specialist recontouring | Replace ongoing management of the facial skin | Guided by the specialist team | Gritty, irritated eyes or lid inflammation; thickened skin at the nose |
A rosacea skincare routine should be short, gentle and protective: a mild cleanser, a barrier-supporting moisturiser and daily sunscreen, with anything prescribed applied as directed. Its job is to support the skin barrier, not to treat the condition on its own.
Cleanse with lukewarm water and a fragrance-free, low-foaming cleanser, using fingertips rather than cloths or brushes, and pat dry. Apply any prescribed treatment to dry skin, then a plain moisturiser with barrier ingredients such as ceramides or glycerin. In the morning, finish with a broad-spectrum sunscreen of SPF 30 or above; mineral filters such as zinc oxide are often better tolerated, and a tinted or green-toned formula can soften visible redness.
Leave out what commonly stings or strips: fragrance, alcohol-heavy toners, menthol, witch hazel, scrubs, and high-strength exfoliating acids or retinoids unless they have been prescribed for you. Introduce one new product at a time, testing it along the jaw for a few days first, so that a reaction can be traced. If the face burns or flushes with almost everything, that is a sign the inflammation needs treating rather than another product swap.
| Feature | Rosacea | Acne | Perioral dermatitis | Demodex (demodicosis) |
|---|---|---|---|---|
| Typical age and distribution | Adults, often from the thirties; central cheeks, nose, chin and forehead | Teens and adults; face, chest and back | Young to middle-aged adults; around the mouth and nose, sometimes the eyes, often sparing a narrow band at the lip border | Adults; central face, frequently alongside rosacea |
| Comedones (blackheads, whiteheads) | Absent | Present | Absent | Absent |
| Background skin | Persistent redness, flushing and visible vessels | Mixed lesions, with redness mainly around them | Small papules and pustules on red, often scaly skin | Fine scaling and a rough feel, with tiny pustules |
| Common aggravators | Heat, sun, alcohol, spicy food, hot drinks, stress | Hormones, occlusion and some products | Topical steroids, heavy creams and some toothpastes | Oily skin, rosacea and reduced immunity |
| Usual treatment direction | Anti-inflammatory topicals, oral treatment, and inflammation- or vessel-directed laser | Retinoids, benzoyl peroxide, antibiotics or isotretinoin | Stopping the trigger, especially steroids, then topical or oral anti-inflammatory treatment | Topical treatment acting on mites, such as ivermectin |
The most consistent triggers are heat, sun, alcohol, spicy food, hot drinks and emotional stress. Hot showers, saunas, vigorous exercise and harsh skincare can add to them. Triggers differ between people, so a short diary of flares is useful to bring to a consultation. In Singapore, heat and sun are hard to avoid, which is why treatment also aims to lower the baseline.
Sometimes. A low-dose oral retinoid may be considered for stubborn inflammatory rosacea that has not settled with other treatment. It is available on prescription, needs blood tests and monitoring, and requires strict pregnancy prevention, so it does not suit everyone. Side effects, pregnancy plans and other medicines are reviewed first, and it is weighed against topical and other oral options at consultation.
Yes. A steroid cream can blanch redness for a while, and then the redness and bumps rebound, sometimes worse than before. Stopping suddenly can also cause a flare, so do not stop a prescribed cream on your own. Bring the cream to your consultation, and a plan to come off it, with treatment to settle the skin, is agreed with you.
Rosacea is diagnosed by examination and history rather than by a single test. The doctor looks at where the redness sits, whether there are bumps without blackheads, visible vessels, thickening or eye symptoms, and asks about flushing and triggers. Conditions that can look similar, such as acne, perioral dermatitis, contact dermatitis and Demodex overgrowth, are considered, and tests are arranged where needed.
No. Sensitive skin describes a reactivity to products or environment. Rosacea is a chronic inflammatory condition of the facial skin involving the blood vessels and the immune response, with a characteristic distribution across the central face. Treating rosacea as though it were product sensitivity leads people to cycle through gentler and gentler skincare while the underlying inflammation continues.
Erythematotelangiectatic, characterised by persistent central facial redness and visible vessels. Papulopustular, with inflammatory papules and pustules that are frequently mistaken for acne. Phymatous, involving thickening of the skin, most often at the nose. And ocular, affecting the eyes with dryness, grittiness and irritation. More than one subtype can be present at once, and they do not respond identically.
Heat is one of the most consistently reported triggers, and ambient temperature and humidity here are high year-round. Sun exposure is a second major trigger and UV is high throughout the year. Neither is avoidable in the way a dietary trigger might be, which is why management here often focuses more on reducing the inflammatory baseline than on trigger avoidance alone.
Rosacea is chronic and relapsing. It is managed rather than cured, and any honest discussion says so at the start. Treatment is directed at reducing inflammatory activity, addressing visible vessels, and lengthening the intervals between flares. Ongoing management is usually part of the plan.
The papulopustular subtype produces inflammatory papules and pustules that look like acne to most people, including some clinicians. The distinguishing features are the absence of comedones, the central facial distribution, and the background erythema. Treating it as acne with aggressive drying agents typically makes the barrier dysfunction worse.
Rosacea involves both an inflammatory component and a vascular one. Approaches directed at inflammatory activity in the skin act on the process rather than only on the visible result. Where telangiectasia is established, the vessels themselves are a separate target. Which applies, and in what order, is decided by examination rather than by subtype label alone.
Barrier support matters, because barrier dysfunction is part of the picture rather than incidental to it. What reliably makes rosacea worse is the opposite approach: aggressive exfoliation, high-strength actives and stripping cleansers. Beyond that, skincare supports management rather than replacing it.
Phymatous change involves thickening of the skin and enlargement of the sebaceous glands, most commonly at the nose. It develops gradually and is more common in men. If you have noticed textural thickening rather than only colour change, that is worth raising at assessment, because it is managed differently from the erythematous subtypes.
No. IPL (intense pulsed light) delivers a broad band of filtered wavelengths, whereas a laser delivers a single wavelength at controlled pulse settings. Both are described in the published literature for the vascular side of rosacea, meaning fixed redness and visible vessels, and neither switches off the underlying condition. In Fitzpatrick III to V skin, which predominates in Singapore, wavelength choice and conservative settings matter, because heat is itself a rosacea trigger and pigment change is a risk. Which light-based approach, if any, suits your skin is decided at examination.
Cost depends on which features are present, whether medical management alone or a combined plan with laser is appropriate, and how the plan is staged. Because rosacea is chronic, maintenance is considered separately from the initial phase. A figure given before assessment would not reflect your presentation, so cost is set out clearly at consultation, before anything is agreed.
Not simply. Demodex mites live on most adult faces, but people with papulopustular rosacea tend to carry more of them, and the mites may help drive inflammation in some cases. That is one reason topical ivermectin, which acts on mites as well as inflammation, is used. Demodex overgrowth can also cause an eruption of its own, so the two are distinguished at examination.
Yes. Both are common and they can coexist, particularly in adults. The clue is a mixed picture: comedones point to acne, while background redness, flushing and a central distribution point to rosacea. It matters because harsh acne treatments can aggravate rosacea, so the plan is built around both conditions rather than one.
Question not answered here? Ask on WhatsApp, use the enquiry form, or browse 100 questions patients ask.
Rosacea — StatPearls. National Center for Biotechnology Information. source
Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. Journal of the American Academy of Dermatology, 2018. pubmed.ncbi.nlm.nih.gov
Laser and light-based therapies in the management of rosacea: an updated systematic review. Lasers in Medical Science, 2021. pubmed.ncbi.nlm.nih.gov
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. British Journal of Dermatology, 2020. pubmed.ncbi.nlm.nih.gov
What is rosacea?. Dermatological Society of Singapore. www.dermatology.org.sg
Clinical characteristics and management of patients with rosacea in a tertiary dermatology center in Singapore from 2009 to 2013. International Journal of Dermatology, 2018. pubmed.ncbi.nlm.nih.gov
Mirvaso gel 3 mg/g (brimonidine), SIN14828P: product information. National Drug Formulary, Government of Singapore. www.ndf.gov.sg
Consultations by appointment at Orchard Road, Singapore.
Replies within clinic hours: Mon–Fri 10am–8pm, Sat 11am–3pm · How consultations work · Prefer not to use WhatsApp? · Treatment finder
WhatsApp +65 8023 7170 →